TABLE 2.
PANI‐based biomaterials applied in cardiac tissue engineering applications
| Biomaterials | Cells | Main Results | In vitro/in vivo | References |
|---|---|---|---|---|
| PANI/Polyethersulfone | Cardiovascular disease‐specific induced pluripotent stem cells | Increased cell number | +/− | 224 |
| PANI/PLGA | CMs | Enhanced cell adhesion | +/− | 225 |
| Tetra‐aniline/PEG | C2C12 Myoblast | Enhanced MI regeneration | +/− | 226 |
| Tetra‐aniline/PEG/hyaluronic acid | Adipose‐derived stem cells (ADSCs) | Enhanced endothelial and muscle cell homing, enhanced MI regeneration | −/+ | 227 |
| PU/siloxane/tetra aniline | CMs | Enhanced cell function even without external electrical stimulation | +/− | 228 |
| PANI/PLA | C cell | Enhanced cell viability and proliferation | +/− | 101 |
| PCL‐aniline trimer | C2C12 Myoblast | Enhanced cell proliferation and myogenic differentiation | +/− | 229 |
| Poly(citric acid‐copolycaprolactone)‐aniline hexamer | C2C12 Myoblast | Excellent cytocompatibility | +/+ | 230 |
| Terta aniline‐ poly(n‐iso propyl acrylamide) | H9c2 cells (rat cardiac myoblast) | High cell viability | +/+ | 231 |
| Polyurethane–aniline pentamer/PCL | CMs | Enhanced cell proliferation and adhesion, proper cardiac gene expression | +/− | 104 , 163 |